American Journal of Ophthalmology
Volume 142, Issue 5 , Pages 726-729.e1 , November 2006

In vitro Activity of Fluoroquinolones, Vancomycin, and Gentamicin Against Methicillin-Resistant Staphylococcus aureus Ocular Isolates

,Accepted 11 June 2006.

References 

  1. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis. 2003;36:131–139
  2. Eiferman RA, O’Neill KP, Morrison NA. Methicillin-resistant Staphylococcus aureus corneal ulcers. Ann Ophthalmol. 1991;23:414–415
  3. Fukuda M, Ohashi H, Matsumoto C, et al. Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococcus ocular surface infection efficacy of chloramphenicol eye drops. Cornea. 2002;21:S86–S89
  4. Kubo M, Sakuraba T, Arai Y, et al. Dacryocystorhinostomy for dacryocystitis caused by methicillin-resistant Staphylococcus aureus: report of four cases. Jpn K Ophthalmol. 2002;46:177–182
  5. Kotlus BS, Rodgers IR, Udell IJ. Dacryocystitis caused by community-onset methicillin-resistant Staphylococcus aureus. Ophthal Plast Reconst Surg. 2005;21:371–375
  6. Oshima Y, Ohiji M, Inoue Y, et al. Methicillin-resistant Staphylococcus aureus infections after scleral buckling procedures for retinal detachments associated with atopic dermatitis. Ophthalmology. 1999;106:142–147
  7. Labit CM, Claeys GW, Verbraeken HE, et al. Methicillin resistance of bacteria isolated from vitreous fluid from patients undergoing vitrectomy. Eur J Ophthalmol. 2001;11:160–165
  8. Barza M. Use of quinolones for treatment of ear and eye infections. Eur J Clin Microbiol Infect Dis. 1991;10:296–303
  9. Kowalski RP, Dhaliwal DK. Ocular bacterial infections: current and future treatment options. Expert Rev Anti Infect Ther. 2005;3:131–139
  10. Marangon FB, Miller D, Muallem MS, et al. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. Am J Ophthalmol. 2004;137:453–458
  11. Weber SG, Gold HS, Hooper DC, et al. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis. 2003;9:1415–1422
  12. Mather R, Karenchak LM, Romanowski EG, Kowalski RP. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol. 2002;133:463–466
  13. Isenberg HD. Clinical Microbiology Procedures Handbook. Washington, D.C: American Society for Microbiology; 1992;
  14. Clinical and Laboratory Standards Institute (CLSI, formerly National Committee for Clinical and Laboratory Standards/NCCLS). Performance standards for antimicrobial susceptibility testing Clinical and Laboratory Standards Institute. 2005;Wayne, PA 15th informational supplement M100–S15
  15. Matsuzaki K, Koyama H, Watabe E, et al. Antimicrobial susceptibility surveillance of recent isolates from ophthalmological infections to gatifloxacin and other antimicrobial drugs. Jpn J Antibiot. 2005;58:45–49
  16. Ling ML, Tan PL. In vitro activity of moxifloxacin against local bacterial isolates. Ann Acad Med Singapore. 2001;30:607–610
  17. Leeming JP. Treatment of ocular infections with topical antibacterials. Clin Pharmacokinet. 1999;37:351–360
  18. Solomon R, Donnenfeld ED, Perry HD, Snyder RW, Nedrud C, Stein J, et al. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. Ophthalmology. 2005;112:466–469
  19. Wada T, Naka H, Tokushige H, et al. Treatment of rabbit corneal infections with ophthalmic gatifloxacin: a concentration dependence study. Adv Ther. 2004;21:1–12
  20. Aliprandis E, Ciralsky J, Lai H, et al. Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits. Cornea. 2005;24:201–205
  21. Solomon R, Donnenfeld ED, Perry HD, et al. Bilateral methicillin-resistant Staphylococcus aureus keratitis in a medical resident following an uneventful bilateral photorefractive keratectomy. Eye Contact Lens. 2003;29:187–189
  22. Deramo VA, Lai JC, Fastenberg DM, et al. Acute endophthalmitis in eyes treated prophylactically with fourth-generation fluoroquinolone antibiotics. Am J Ophthalmol Forthcoming.
  23. Moshirfar M, Marx DP, Mirzaian G. Endophthalmitis in patients using fourth-generation fluoroquinolones following phacoemulsification. J Cataract Refract Surg. 2005;31:1669–1670
  24. Hiramatsu K, Cui L, Kuroda M, et al. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol. 2001;9:486–493
  25. Wenzel RP. The antibiotic pipeline—challenges, costs, and values. N Engl J Med. 2004;351:523–526

PII: S0002-9394(06)00725-2

doi: 10.1016/j.ajo.2006.06.030

American Journal of Ophthalmology
Volume 142, Issue 5 , Pages 726-729.e1 , November 2006

Article Tools